Van Bambeke, F., Saffran, J., Mingeot-Leclercq, M., & Tulkens, P. M. (2005). Mixed-Lipid Storage Disorder Induced in Macrophages and Fibroblasts by Oritavancin (LY333328), a New Glycopeptide Antibiotic with Exceptional Cellular Accumulation. American Society for Microbiology.
Chicago Style CitationVan Bambeke, Françoise, Jennifer Saffran, Marie-Paule Mingeot-Leclercq, i Paul M. Tulkens. Mixed-Lipid Storage Disorder Induced in Macrophages and Fibroblasts By Oritavancin (LY333328), a New Glycopeptide Antibiotic With Exceptional Cellular Accumulation. American Society for Microbiology, 2005.
Cita MLAVan Bambeke, Françoise, Jennifer Saffran, Marie-Paule Mingeot-Leclercq, i Paul M. Tulkens. Mixed-Lipid Storage Disorder Induced in Macrophages and Fibroblasts By Oritavancin (LY333328), a New Glycopeptide Antibiotic With Exceptional Cellular Accumulation. American Society for Microbiology, 2005.